1 completed, 1 terminated, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow 10-carboxymethyl-9-acridanone: new trials by email Literature Review of 10-carboxymethyl-9-acridanone trials Research Report on 10-carboxymethyl-9-acridanone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza Cycloferon, Placebo - Influenza, Acute Respiratory Infection | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 166 | 2023-09-15 | 2025-04-29 |
| An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer Sodium Cridanimod, progestin therapy - Endometrial Cancer | Phase 2 | Terminated | Xenetic Biosciences, Inc. | 25 | 2017-06-14 | 2022-06-07 |
| Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA Sodium cridanimod - Recurrent or Persistent Endometrial Carcinoma | Phase 2 | Unknown | Kevelt AS | 8 | 2014-09-01 | 2017-01-24 |
Endometrial Neoplasms (2) · Recurrence (2) · Influenza, Human (1)
Kevelt AS (1) · POLYSAN Scientific & Technological Pharmaceutical Company (1) · Xenetic Biosciences, Inc. (1)
United States (2) · Belarus (1) · Czechia (1) · Russia (1) · Slovakia (1) · Ukraine (1)
Curtis Lockshin, PhD (1) · Laura L. Douglass (1) · Tatiana V Kharitonova, MD PhD (1)